Targeted disruption of the galectin-3 gene results in decreased susceptibility to multiple low dose streptozotocin-induced diabetes in mice

Clinical Immunology

Volumn 130, Issue 1, 2009, Pages 83-88

  Mensah Brown, E P K ^a   Al Rabesi, Z ^a   Shahin, A ^a   Al Shamsi, M ^a   Arsenijevic, N ^b   Hsu, D K ^c   Liu, F T ^c   Lukic, M L ^a,b  

^a UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

^b UNIVERSITY OF KRAGUJEVAC   (Serbia)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Autoimmunity; ; Inducible nitric oxide synthase; ; Interferon gamma; ; Interleukin 17; Proinflammatory cytokines;

Indexed keywords

CYTOKINE; GALECTIN 3; GAMMA INTERFERON; GLUCOSE; INDUCIBLE NITRIC OXIDE SYNTHASE; INSULIN; INTERLEUKIN 17; STREPTOZOCIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIABETES MELLITUS; DIABETOGENESIS; DISEASE PREDISPOSITION; GENE DISRUPTION; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; INSULIN BLOOD LEVEL; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DISEASE SUSCEPTIBILITY; GALECTIN 3; GENE DELETION; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; LIPOPOLYSACCHARIDES; LYMPH NODES; MICE; MICE, KNOCKOUT; NITRIC OXIDE; STREPTOZOCIN;

EID: 57149129697     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2008.08.024     Document Type: Article

References (30)

1. Cooper D.N.W. Galectinomics: finding themes in complexity. Biochem. Biophys. Acta 1572 (2002) 209-3l
2. Dumic J., Dabelic S., and Flögel M. Galectin-3: an open-ended story. Biochim. Biophys. Acta 1760 (2007) 616-635
3. Tuscano M.A., Ilarregui J.M., Bianco G.A., Campagna L., Croci D.A., Salatino M., and Rabinovich G.A. Dissecting the pathophysiologic role of endogenous lectins: glycan-binding proteins with cytokine-like activity?. Cytokine Growth Factor Rev. 18 (2007) 57-71
4. Rabinovich G.A., Castagna L.F., Landa C.A., Riera C.M., and Sotomayor C.E. Regulated expression of a 16 kDa galectin-like protein in activated rat macrophages. J. Leukoc. Biol. 59 (1996) 363-370
5. Yang R.Y., Hsu D.K., and Liu F.T. Expression of galectin-3 modulates T cell growth and apoptosis. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 6737-6742
6. Fukumori T., Takenaka Y., Yoshii T., Kim H.R., Hogan V., Inohara H., Kagawa S., and Raz A. CD27 and CD7 mediate galectin-3-induced type II T-cell apoptosis. Cancer Res. 63 (2003) 8302-1l
7. Rabinovich G.A., Daly G., Dreja H., Tailor H., Riera C.M., Hirabayashi J., and Chernajovsky Y. Recombinant galectin-l and its genetic delivery suppress collagen-induced arthritis via T cell apoptosis. J. Exp. Med. 190 (1999) 385-397
8. Offner H., Celnik B., Bringman T., Casentini-Borocz D., Nedwin G.E., and Vanderbark A.A. Recombinant human β-galactoside-binding lectin suppresses clinical and histological signs of experimental autoimmune encephalomyelitis. J. Neuroimmunol. 28 (1990) 177-184
9. Santucci L., Fiorucci S., Rubinstein N., Mencarelli A., Palazetti B., Federici B., Rabinovich G.A., and Morelli A. Galectin-l suppresses experimental colitis in mice. Gastroenterology 124 (2003) 1381-1394
10. Santucci L., Fiorucci S., Cammilleri F., Servillo G., Federici B., and Morelli A. Galectin-1 exerts immunomodulatory and protective effects on concavalin A-induced hepatitis in mice. Hepatology 31 (2000) 399-406
11. Hsu D.K., Yang R.Y., Pan Z., Yu L., Salomon D.R., Fung-Leung W.P., and Liu F.-T. Targeted disruption of the galectin-3 gene results in attenuated peritoneal inflammatory responses. Am. J. Pathol. 156 (1994) 1073-1083
12. Like A.A., and Rossini A.A. Streptozotocin-induced pancreatic insulitis: new model of diabetes mellitus. Science 193 (1976) 415-417
13. Lukic M.L., Stosic-Grujicic S., Ostojic N., Chan W.L., and Liew F.Y. Inhibition of nitric oxide generation affects the induction of diabetes by streptozotocin in mice. Biochem. Biophys. Res. Commun. 178 (1991) 913-920
14. Mensah-Brown E.P.K., Shahin A., Al-Shamisi M., Wei X., and Lukic M.L. Interleukin 23 leads to diabetes induction after subdiabetogenic treatment with multiple doses of streptozotocin. Eur. J. Immunol. 1 (2006) 216-223
15. Eldor R., Yeffer A., Baum K., Doviner V., Amar D., Ben-Neriah Y., Christofori G., Peled A., Carel J.C., Boitard C., Klein T., Serup P., Eizirik D.L., and Melloul D. Conditional and specific NF-{kappa}B blockade protects pancreatic beta cells from diabetogenic agents. Proc. Natl. Acad. Sci. 103 (2006) 5072-5077
16. Guevara I., Iwanejko J., Dembińska-Kieć A., Pankiewicz J., Wanat A., Anna P., Gołabek I., Bartuś S., Malczewska-Malec M., and Szczudlik A. Determination of nitrite/nitrate in human biological material by the simple Griess reaction. Clin. Chim. Acta 274 (1998) 177-188
17. Bettelli E., Oukka M., and Kuchroo V.K. Th-17 cells in the circle of immunity and autoimmunity. Nat. Immunol. 8 (2007) 345-350
18. Joo H.G., Goedegebuure P.S., Sadanaga N., Nagoshi M., Von Bertoff W., and Eberlein T.J. Expression and function of galectin-3, a beta galactoside binding protein in activated lymphocytes. J. Leukoc. Biol. 69 (2001) 555-564
19. Sano H., Hsu D.K., Apgar J.R., Sharma L.B.B., Kuwabara I., Izui S., and Liu F.-T. Critical role of galectin-3 in phagocytosis by macrophages. J. Clin. Invest. 112 (2003) 389-397
20. Jeng K.C., Frigeri L.G., and Liu F.-T. An endogenous lectin, galectin-3 (epsilon BP/Mac-2), potentiates IL-1 production by human monocyte. Immunol. Lett. 42 (1994) 113-116
21. Bernardes E.S., Silva N.M., Ruas L.P., Mineo J.R., Loyola A.M., Hsu D.K., Liu F.-T., Chammas R., and Roque-Barreira M.C. Toxoplasma gondii infection reveals a novel regulatory role for galectin-3 in the interface of innate and adaptive immunity. Am. J. Pathol. 168 (2006) 1910-1920
22. Lukic M.L., Stosic-Grujicic S., and Shahin A. Effector mechanisms in low-dose streptozotocin-induced diabetes. Dev. Immunol. 6 (1998) 119-128
23. Uno S., Imagawa A., Okita K., Sayama K., Noriwaki M., Iwahashi H., Yamagata K., Tamura S., Matsuzawa Y., Hanafusa T., Miyagawa J., and Shimomura I. Macrophages and dendritic cells infiltrating islets with or without beta cells produce tumour necrosis factor-alpha in patients with recent onset type 1 diabetes. Diabetologia 50 (2007) 596-601
24. Karlsen A.E., Storling Z.M., Sparre T., Larsen M.R., Mahmood A., Storling J., Roepstorff P., Wrzesinski K., Larsen P.M., Fey S., Nielsen K., Kristiansen O.P., Christensen U.B., Kockum I., Luthman H., Nerup J., and Pociot F. Immune mediated beta-cell destruction in vitro and in vivo - a pivotal role for galectin-3. Biochem. Biophys. Res. Commun. 26 (2006) 406-415
25. Cnop M., Welsh N., Jonas J.C., Jörns A., Lenzen S., and Eizirik D.L. Mechanisms of pancreatic beta-cell death in type 1 and type 2 diabetes: many differences, few similarities. Diabetes 54 (2005) S97-107
26. Miljkovic D., Cvetkovic I., Momcilovic M., Maksimovic-Ivanic D., Stosic-Grujicic S., and Trajkovic V. Interleukin-17 stimulates inducible nitric oxide synthase-dependent toxicity in mouse beta cells. Cell. Mol. Life Sci. 62 (2005) 2658-2668
27. Breuilh L., Vanhoutte F., Fontaine J., van Stijn C.M.W., Tillie-Leblond I., Capron M., Faveeuw C., Jouault T., van Die I., Gosset P., and Trottein F. Galectin-3 modulates immune and inflammatory responses during helminthic infection: impact of galectin-3 deficiency on the functions of dendritic cells. Infect. Immun. 75 (2007) 5148-5157
28. Perone M.J., Bertera S., Tawadrous Z.S., Shufesky W.J., Piganell J.D., Baum L.G., Trucco M., and Morelli A.E. Dendritic cells expressing transgenic galectin-1 delay onset of autoimmune diabetes in mice. J. Immunol. 177 (2006) 5278-5289
29. + T cells-induced diabetes, macrophages are the final effectors cells that mediate islet β-cell killing. Am. J. Pathol. 109 (2006) 2137-2147
30. Lippert E., Falk W., Bataille F., Kaehne T., Naumann M., Goeke M., Herfarth H., Schoelmerich J., and Rogler G. Soluble galectin-3 is a strong, colonic epithelial-cell-derived lamina propria fibroblast-stimulating factor. Gut 56 (2007) 43-51